SELB - Selecta Biosciences - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

SELB is currently covered by 1 analysts with an average potential upside of $7.21 (151.44%) backed by displayed 7 price targets and 20 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5.56% with an average time for these price targets to be met of 21.11 days.

Highest price target for SELB is 2, Lowest price target is 2, average price target is 2.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 18-Aug-2023. First documented stock forecast 08-Dec-2016.

Currently, out of the existing stock ratings of SELB - 1 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

4

$2.9 (263.64%)

5

3 months 11 days ago

0/5 (0%)

$3.38 (232.59%)

Buy

3

$1.9 (172.73%)

4

3 months 11 days ago

0/5 (0%)

$2.84 (144.30%)

Buy

5

$3.9 (354.55%)

5

3 months 11 days ago

0/4 (0%)

$3.5 (283.68%)

Buy

9 months 29 days ago

0/1 (0%)

$6.62 (28.31%)

Hold

9

$7.9 (718.18%)

2 years 3 days ago

0/1 (0%)

$6.1 (210.34%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SELB (Selecta Biosciences) average time for price targets to be met?

On average it took 21.11 days on average for the stock forecasts to be realized with a an average price target met ratio 5.56

Which analyst has the current highest performing score on SELB (Selecta Biosciences) with a proven track record?

DIFEI YANG

Which analyst has the current lower performing score on SELB (Selecta Biosciences) with a proven track record?

YUN ZHONG

Which analyst has the most public recommendations on SELB (Selecta Biosciences)?

Difei Yang works at MIZUHO and has 12 price targets and 20 ratings on SELB

Which analyst is the currently most bullish on SELB (Selecta Biosciences)?

Chad Messer with highest potential upside - $26.9

Which analyst is the currently most reserved on SELB (Selecta Biosciences)?

Difei Yang with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart